Boston Scientific (NYSE:BSX – Free Report) had its price objective raised by Piper Sandler from $95.00 to $115.00 in a research note issued to investors on Monday morning,Benzinga reports. They ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback